GlassScriptPhysician profile
David M Dickerson
NPI 1548581226
$557,948.24
in general payments reported to CMS, 2019-2025
28 companies · $142K in 2025
The $142K reported for 2025 was more than what 99% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $10K · 2021: $47K · 2022: $123K · 2023: $124K · 2024: $88K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $185K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $48K · Travel and Lodging: $47K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Food and Beverage: $29K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $185,074.27 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $47,549.44 |
| Travel and Lodging | $46,627.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,052.51 |
| Food and Beverage | $28,825.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $271,481.61 | 2019-2025 | Proclaim, Eterna, Infinity |
| Spr Therapeutics, INC | $88,135.07 | 2019-2025 | Sprint Pns System |
| Vertos Medical, INC. | $77,108.61 | 2019-2024 | Mild Device Kit |
| Stryker Corporation | $63,374.89 | 2021-2025 | Mild Device Kit, Spinejack, Pcd |
| Biotronik Nro, INC. | $28,342.45 | 2023-2025 | Prospera, Biotronik |
| Pfizer INC. | $6,300.00 | 2021 | |
| Fresenius Kabi USA, LLC | $5,761.47 | 2019 | |
| Nalu Medical, INC. | $4,635.22 | 2021-2025 | Nalu Neurostimulation System |
| Myovant Sciences INC. | $4,280.00 | 2022 | |
| Nevro Corp. | $1,919.80 | 2019-2023 | Senza |
| Medtronic, INC. | $1,840.58 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Bis |
| Vertiflex, INC. | $1,774.51 | 2019 | |
| Boston Scientific Corporation | $1,018.60 | 2020-2025 | Wavewriter Alpha Prime 16, Bulkamid |
| Saluda Medical Americas, INC. | $683.22 | 2022-2025 | Evoke Scs, Evoke |
| Spinal Simplicity, LLC | $250.14 | 2024-2025 | Ha Minuteman G3-R |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $199.39 | 2023 | Stimrouter Implantable Kit |
| Grt US Holding, INC. | $127.11 | 2022 | |
| Tersera Therapeutics LLC | $123.85 | 2025 | Prialt |
| Si-Bone, INC. | $109.91 | 2023-2025 | |
| Curonix LLC | $108.84 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medtronic USA, INC. | $100.14 | 2019-2020 | |
| Relievant Medsystems, INC. | $66.19 | 2023 | Intracept |
| Mml US, INC. | $62.42 | 2023 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $44.83 | 2024 | Exparel, Zilretta, Iovera |
| Heron Therapeutics, INC. | $44.47 | 2022-2023 | Aponvie |
| Edwards Lifesciences Corporation | $23.37 | 2019 | |
| Zimvie INC. | $18.49 | 2023 | |
| Painteq LLC | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.